Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
Saved in:
| Title: | Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial. |
|---|---|
| Authors: | Blauvelt, Andrew, Leonardi, Craig L., Gooderham, Melinda, Papp, Kim A., Philipp, Sandra, Wu, Jashin J., Igarashi, Atsuyuki, Flack, Mary, Geng, Ziqian, Wu, Tianshuang, Camez, Anne, Williams, David, Langley, Richard G. |
| Source: | JAMA dermatology Jun2020; Vol. 156 (6). |
| Journal Info: | Publisher: American Medical Association ISSN: 2168-6068 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
